The Chemours Company

CC

US1638511089

Diversified Chemicals

Market Closed - Nyse Other stock markets 01:30:02 17/05/2024 am IST			5-day change	1st Jan Change
28.87 ^USD	-0.89%		+1.55%	-8.47%

06/05	Hudson Technologies Signs Licensing Agreement With Chemours	MT
06/05	Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Monday; Palantir to Advance, Trump Media & Technology Group to Decline	MT

The Chemours Company Provides Earnings Guidance for the Second Quarter of 2024

April 01, 2024 at 02:00 am IST

The Chemours Company provided earnings guidance for the second quarter of 2024. For the second quarter of 2024, the company expects consolidated Net Sales to increase approximately 15% sequentially, with consolidated Adjusted EBITDA also up approximately 15% compared with first quarter 2024 results.

Latest news about The Chemours Company

Hudson Technologies Signs Licensing Agreement With Chemours	06/05	MT
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Monday; Palantir to Advance, Trump Media & Technology Group to Decline	06/05	MT
Chemours Discontinues Sales of Legacy Refrigerants in US	02/05	MT
Trans Mountain Pipeline's C$34-Billion Expansion Project Enters Commercial Service	01/05	MT
Transcript : The Chemours Company, Q1 2024 Earnings Call, May 01, 2024	01/05
Earnings Flash (CC) THE CHEMOURS COMPANY Posts Q1 Revenue $1.35B, vs. Street Est of $1.41B	01/05	MT
Earnings Flash (CC) THE CHEMOURS COMPANY Reports Q1 EPS $0.32, vs. Street Est of $0.17	01/05	MT
The Chemours Company Provides Earnings Guidance for the Second Quarter of 2024	01/05	CI
The Chemours Company Reports Earnings Results for the First Quarter Ended March 31, 2024	01/05	CI
Chemours Keeps Quarterly Cash Dividend at $0.25 a Share, Payable June 14 to Shareholders of Record on May 15	30/04	MT
The Chemours Company Announces Dividend for the Second Quarter of 2024, Payable on June 14, 2024	30/04	CI
Well, it isn't as bad as feared...	26/04
Chemours CFO Jonathan Lock steps down after financial revisions	26/04	RE
North American Morning Briefing : Traders Await -2-	10/04	DJ
BMO Capital Upgrades Chemours to Outperform From Underperform, Raises Price Target to $34 From $19	09/04	MT
UBS Adjusts Chemours Price Target to $28 From $21, Maintains Neutral Rating	02/04	MT
Materials Gain After Strong Economic Data - Materials Roundup	29/03	DJ
Chemours falls on weak quarterly sales forecast after internal review	29/03	RE
Investors only care for Easter	28/03
News Highlights : Top Company News of the Day - Thursday at 9 AM ET	28/03	DJ
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Key Economic Data	28/03	MT
Transcript : The Chemours Company, Q4 2023 Earnings Call, Mar 28, 2024	28/03
Chemours Identifies Weaknesses in Internal Financial Controls Following Audit Committee Review	28/03	MT
News Highlights : Top Company News of the Day - Thursday at 7 AM ET	28/03	DJ
North American Morning Briefing : Stocks Set for Tepid Start as Inflation Data Eyed	28/03	DJ

Chart The Chemours Company

Duration

Period

More charts

Company Profile

The Chemours Company is a provider of performance chemicals, which is engaged in providing customized solutions with a range of industrial and specialty chemicals products for markets. Its segments include Titanium Technologies, Thermal & Specialized Solutions and Advanced Performance Materials. Titanium Technologies segment is a provider of titanium dioxide pigment, a premium white pigment used to deliver whiteness, brightness, opacity and protection in various applications. The Thermal & Specialized Solutions segment is a provider of refrigerants, thermal management solutions, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment is a provider of high-end polymers and advanced materials. Its flagship products include brands such as Ti-Pure, Opteon, Freon, Teflon, Viton, Nafion, and Krytox. It operates in approximately 28 production facilities located in eight countries and serves 2,700 customers across a range of end markets in 110 countries.

Sector

Diversified Chemicals

Calendar

21/05/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for The Chemours Company

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

28.87 USD

Average target price

30.56 USD

Spread / Average Target

+5.84%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diversified Chemicals

	1st Jan change	Capi.
THE CHEMOURS COMPANY	-8.47%	4.3B
SHIN-ETSU CHEMICAL CO., LTD.	-1.55%	76.24B
BASF SE	+0.60%	47.61B
DUPONT DE NEMOURS, INC.	+0.83%	32.43B
PIDILITE INDUSTRIES LIMITED	+10.55%	18.39B
EASTMAN CHEMICAL COMPANY	+11.41%	11.77B
BRENNTAG SE	-16.13%	10.95B
SYENSQO SA/NV	+1.43%	10.94B
ASAHI KASEI CORPORATION	-0.38%	9.21B
SRF LIMITED	-8.32%	8.06B

Diversified Chemicals